Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations (original) (raw)
Figure 4
Nmut and treatment outcome in patients with wtBRCA tumors and no residual disease after initial surgery.
Nmut high and low were defined by values above or below the median Nmut from all wtBRCA tumors in the cohort. A) Kaplan-Meier analysis compared PFS, and B) OS between tumor Nmut high and low in patients with wtBRCA tumors and no residual disease after debulking surgery. Numbers of patients at risk at each interval are given below the graphs. P-values are obtained from Log-rank test.